Advisory Advocates’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$641K Sell
4,377
-413
-9% -$74.8K 0.55% 55
2026
Q1
$705K Buy
4,790
+619
+15% +$101K 0.72% 47
2025
Q4
$813K Buy
+4,171
New +$993K 0.81% 42

Other funds holding ORCL

Advisory Advocates's ORCL Position: Q2 2026 in Review

Advisory Advocates reduced its Oracle (ORCL) stake by 8.6% in Q2 2026, selling an estimated $74.8K and leaving 4,377 shares worth $641K. The position accounts for 0.55% of the portfolio, ranked #55.

Advisory Advocates first reported a position in ORCL in Q4 2025 and has held it in 3 quarters since. The position peaked at $813K in Q4 2025. 3,362 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Advisory Advocates held 4,377 shares of Oracle worth $641K as of Q2 2026.
  • Advisory Advocates sold 413 Oracle shares in Q2 2026, an estimated $74.8K.
  • Oracle made up 0.55% of Advisory Advocates's portfolio in Q2 2026, its #55 holding.
  • Advisory Advocates first reported a position in Oracle in Q4 2025 and has held it in 3 quarters since.
  • Advisory Advocates's Oracle position peaked at $813K in Q4 2025.
  • 3,362 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Advisory Advocates's 13F filing for Q2 2026, filed 10 Aug 2026.